home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Protecting Mothers From Fetal Immune Recognition

 
  October, 27 2006 14:29
your information resource in human molecular genetics
 
     
A protein expressed in developing embryos may protect mothers against immune-mediated attack by fetal cells, according to a study to be published in the December 2006 issue of Nature Immunology.

This protein, called Zfp608, appears to function by switching off the expression of Rag genes, which are involved in the development and function of fetal immune cells.

Thomas Aune and colleagues identified Zfp608 by honing in on a genetic defect exhibited by a strain of mice called ZORI, which have a compromised immune system. These mice have reduced numbers of T lymphocytes, immune cells that develop in the thymus. Normally mice express Zfp608 during embryonic development but stop its expression soon after birth. In contrast, ZORI mice continue to express Zfp608 in their thymus well beyond birth; continued Zfp608 expression is therefore linked to lack of thymic immune cell development.

The authors show that Zfp608 inhibits Rag gene expression in thymic cells, which explains the defect in T lymphocyte development observed in ZORI mice. They speculate that the timing of Zfp608 expression in embryos might play a protective role by preventing the development of fetal immune cells that could potentially recognize and attack maternal tissues, thereby harming both mother and her unborn offspring.

Author Contact:

Thomas M Aune (Vanderbilt University School of Medicine, Nashville, TN, USA)
E-mail: thomas.aune@vanderbilt.edu

Abstract available online.

(C) Nature Immunology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.